TrialCancer discovery2014

MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF/MEK inhibition.

Nikhil Wagle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.